Context: CSIR-NAL scientists indigenously designed and developed the non-invasive bi-level positive airway pressure ventilator –SwasthVayu, with additional features to treat Covid-19 patients and make the country self-reliant.

• The performance of the device has been evaluated by the expert committee constituted by Director General of Health Services, Ministry of Health & Family Welfare, Government of India.
• The expert committee, after careful evaluation, has concluded that SwasthVayu may be used on Covid-19 patients who require oxygen supplementation up to 35%.

SwasthVayu

• Developed by CSIR-NAL, it is a microcontroller based precise closed-loop adaptive control system with a built-in biocompatible “3D printed manifold and coupler” with HEPA filter (Highly Efficient Particulate Air Filter).
• These unique features help to alleviate the fear of the virus spread.
• It has features like CPAP, Bi-Timed, Spontaneous / AUTO modes with provision to connect Oxygen concentrator or Enrichment unit externally.
• The ventilator has gone through stringent tests for Electrical safety, performance and biocompatibility at NABL accredited agency.
• The SwasthVayu has successfully conducted clinical trials at Command Hospital, Bangalore and Mysore Medical College & Research Institute, Mysore on 50 Covid-19 patients.
• The clinical trial reports clearly bring out that the performance of “SwasthVayu” ventilator device is satisfactory and effective in improving saturation during use for Covid-19 patients.
• CSIR-NAL has commercialized this technology with six private companies and one of these companies (which are in the MSME category) has set up the production facilities for almost 300 units per week.

https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1686357

Download PDF